Clinical Trial Update: Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial is evaluating the combination of sorafenib with radiotherapy for advanced hepatocellular carcinoma; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: China Medical University Hospital | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN